HighRes, Novo Nordisk work on robotic drug discovery Life science robotics company HighRes Biosolutions and global healthcare company Novo Nordisk plan to design a robotic platform for high-throughput biologics engineering and characterization of potential drug discovery candidates.
Joint venture targets cell and gene therapy A new joint venture dedicated to supporting researchers and biopharmaceutical companies in cell and gene therapy was announced on January 21. The joint venture is owned equally by three partners: Bio-Techne, Fresenius Kabi, and Wilson Wolf.
LabCorp adopts Thermo Fisher NGS for companion diagnostics LabCorp announced on January 14 that it will adopt Thermo Fisher Scientific's Ion Torrent Genexus next-generation sequencing (NGS) system and Oncomine precision assay for use in research and development of companion diagnostics and precision medicine applications.
Evotec, Bayer partner for drug discovery in women's health Evotec and Bayer announced on January 9 the expansion of their partnership in women's health with a new five-year, multitarget collaboration with participation from Celmatix to develop multiple clinical candidates for the treatment of polycystic ovary syndrome.
Bruker launches new microscopy technology On Monday, December 10, at the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO) meeting, Bruker introduced a brand new product which brings increased options to scientists looking for live-cell 3D imaging.